Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
ALXO · NASDAQ · Pharmaceutical Preparations
$1.06+0.04 (+3.92%)
Close of Nov 20, 2026, vs Nov 19 · end-of-day
Alx Oncology (ALXO) · oqro.io/stocks/ALXO · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
Everything reported about this company, newest first. Each line shows the dates that matter for its source.
5%+ stake · Stake as of Nov 12, 2026 · Filed Nov 19, 2026
Coastlands Capital LP now owns 5.3% of ALXO as a passive investorSource5%+ stake, activist · Stake as of Oct 14, 2026 · Filed Oct 16, 2026
GOODMAN COREY S disclosed a 10.0% stake in ALXO and may seek to influence the companySourceInsider trade · Traded Aug 17, 2026 · Filed Aug 18, 2026
CEO sold ~$4.3K of ALXO shares in the open marketSourceInsider trade · Traded Aug 17, 2026 · Filed Aug 18, 2026
Officer sold ~$1.1K of ALXO shares in the open marketSourceInsider trade · Traded Jul 1, 2026 · Filed Jul 6, 2026
Officer sold ~$2.9K of ALXO shares in the open marketSourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Ra Capital Management, L.P. disclosed a new position in ALXO for Q1 2026SourceInsider trade · Traded Mar 19, 2026 · Filed Mar 23, 2026
CEO sold ~$27K of ALXO shares in the open marketSourceInsider trade · Traded Mar 19, 2026 · Filed Mar 23, 2026
Officer sold ~$2K of ALXO shares in the open marketSourceInsider trade · Traded Feb 18, 2026 · Filed Feb 20, 2026
Officer sold ~$1.3K of ALXO shares in the open marketSourceInsider trade · Traded Feb 2, 2026 · Filed Feb 4, 2026
Director purchased ~$5M of ALXO shares in the open marketSourceInsider trade · Traded Jan 6, 2026 · Filed Jan 7, 2026
Officer sold ~$4.4K of ALXO shares in the open marketSourceInsider trade · Traded Sep 17, 2025 · Filed Sep 18, 2025
CEO purchased ~$77K of ALXO shares in the open marketSourceInsider trade · Traded Sep 16, 2025 · Filed Sep 18, 2025
CEO purchased ~$22K of ALXO shares in the open marketSourceInsider trade · Traded Aug 18, 2025 · Filed Aug 20, 2025
CFO purchased ~$58K of ALXO shares in the open marketSourceInsider trade · Traded Aug 15, 2025 · Filed Aug 19, 2025
CEO sold ~$1.5K of ALXO shares in the open marketSourceInsider trade · Traded Aug 15, 2025 · Filed Aug 19, 2025
Officer sold ~$391 of ALXO shares in the open marketSourceInsider trade · Traded Jul 7, 2025 · Filed Jul 8, 2025
Officer sold ~$905 of ALXO shares in the open marketSourceInsider trade · Traded Jun 30, 2025 · Filed Jul 1, 2025
Officer sold ~$659 of ALXO shares in the open marketSourceInsider trade · Traded Feb 19, 2025 · Filed Feb 21, 2025
CEO sold ~$2.5K of ALXO shares in the open marketSourceInsider trade · Traded Feb 19, 2025 · Filed Feb 21, 2025
Officer sold ~$633 of ALXO shares in the open marketSourceInsider trade · Traded Feb 19, 2025 · Filed Feb 21, 2025
Officer sold ~$1.5K of ALXO shares in the open marketSourceInsider trade · Traded Jan 6, 2025 · Filed Jan 8, 2025
CFO sold ~$4K of ALXO shares in the open marketSourceInsider trade · Traded Dec 30, 2024 · Filed Jan 2, 2025
CFO sold ~$2.3K of ALXO shares in the open marketSourceInsider trade · Traded Dec 30, 2024 · Filed Jan 2, 2025
Officer sold ~$17K of ALXO shares in the open marketSourceInsider trade · Traded Dec 2, 2024 · Filed Dec 4, 2024
Director purchased ~$46K of ALXO shares in the open marketSourceFund moves · Holdings as of Sep 30, 2024 (Q3 2024) · Filed Nov 14, 2024
Paradigm Biocapital Advisors LP no longer reported ALXO for Q3 2024Source